Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-8-31
pubmed:abstractText
To explore the predictive value of estrogen-regulated gene changes as indicators of sensitivity in ovarian cancer patients treated with the aromatase inhibitor Letrozole.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0090-8258
pubmed:author
pubmed:issnType
Print
pubmed:volume
106
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
461-8
pubmed:meshHeading
pubmed-meshheading:17624412-Antineoplastic Agents, pubmed-meshheading:17624412-Aromatase Inhibitors, pubmed-meshheading:17624412-Breast Neoplasms, pubmed-meshheading:17624412-Cell Line, Tumor, pubmed-meshheading:17624412-Estradiol, pubmed-meshheading:17624412-Estrogens, pubmed-meshheading:17624412-Female, pubmed-meshheading:17624412-Gene Expression Regulation, Neoplastic, pubmed-meshheading:17624412-Humans, pubmed-meshheading:17624412-Immunohistochemistry, pubmed-meshheading:17624412-Nitriles, pubmed-meshheading:17624412-Ovarian Neoplasms, pubmed-meshheading:17624412-Predictive Value of Tests, pubmed-meshheading:17624412-RNA, Messenger, pubmed-meshheading:17624412-Receptors, Estrogen, pubmed-meshheading:17624412-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:17624412-Triazoles
pubmed:year
2007
pubmed:articleTitle
Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer.
pubmed:affiliation
Edinburgh Cancer Research Centre, and Department of Pathology, University of Edinburgh, Edinburgh, UK.
pubmed:publicationType
Journal Article, Clinical Trial, Phase II